Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Prostatic Cancer Metastatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01748500
What this trial is testing

Pantoprazole and Docetaxel for Men With Metastatic Castration-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
University Health Network, Toronto 21
Testing effectiveness (Phase 2)Ended earlyNCT03763851
What this trial is testing

Cannabis Oil and Radiation Therapy for the Management of Pain

Who this might be right for
Metastatic Prostate CancerLung CancerBreast Cancer
Tetra Bio-Pharma 100
Testing effectiveness (Phase 2)Study completedNCT01240629
What this trial is testing

Doxorubicin-GnRH Agonist Conjugate AEZS-108 in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer

Who this might be right for
Prostate CancerHormone-resistant Prostate CancerRecurrent Prostate Cancer+1 more
University of Southern California 43
Testing effectiveness (Phase 2)Looking for participantsNCT04573231
What this trial is testing

Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

Who this might be right for
Breast CancerHER2-negative Breast CancerMetastatic Breast Cancer
University of Wisconsin, Madison 13
Testing effectiveness (Phase 2)Looking for participantsNCT06457919
What this trial is testing

Tinengotinib (TT-00420) in Combination With Standard Treatments in People With Prostate Cancer

Who this might be right for
Prostate Cancer
Memorial Sloan Kettering Cancer Center 50
Testing effectiveness (Phase 2)Study completedNCT00140400
What this trial is testing

Prime-Boost Dose Scheduling Trial for Human GM-CSF Gene Transduced Irradiated Prostate Allogeneic Cancer Vaccine (Allogeneic Prostate GVAX®) in Patients With Hormone-Refractory Prostate Cancer

Who this might be right for
Prostate Cancer
Cell Genesys 50
Testing effectiveness (Phase 2)Study completedNCT05059236
What this trial is testing

Learn How Well Darolutamide Administered Together With Androgen Deprivation Therapy (ADT) Works in Men With Metastatic Hormone-sensitive Prostate Cancer. Results Will be Compared With ADT Alone From a Previously Conducted Study.

Who this might be right for
Metastatic Hormone-sensitive Prostate Cancer
Bayer 223
Testing effectiveness (Phase 2)Active Not RecruitingNCT06734130
What this trial is testing

Adaptive Androgen Deprivation and Docetaxel in Metastatic Castration Sensitive Prostate Cancer

Who this might be right for
Metastatic Castration Sensitive Prostate Cancer
H. Lee Moffitt Cancer Center and Research Institute 25
Large-scale testing (Phase 3)Ended earlyNCT00294437
What this trial is testing

ZOMETA® (Zoledronic Acid) for Prevention of Bone Metastases

Who this might be right for
Prostate Cancer
Central European Cooperative Oncology Group 376
Not applicableStudy completedNCT04516707
What this trial is testing

Evaluation of Tolerance and Efficacy Retrospective Data of XOFIGO

Who this might be right for
Prostate CancerBone MetastasesHormone-resistant Prostate Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 67
Not applicableLooking for participantsNCT06546267
What this trial is testing

Advanced Radiotherapy (ART) in Prostate Cancer (PROST-ART)

Who this might be right for
Prostate Cancer
IRCCS San Raffaele 2,500
Large-scale testing (Phase 3)Study completedNCT00134056
What this trial is testing

S0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone Therapy

Who this might be right for
Metastatic CancerProstate Cancer
SWOG Cancer Research Network 1,038
Not applicableEnded earlyNCT00918645
What this trial is testing

Calcium-41 (41Ca) Chloride Aqueous Solution in Diagnosing Patients With Prostate Cancer and Bone Metastasis

Who this might be right for
Metastatic CancerProstate Cancer
University of California, Davis 13
Early research (Phase 1)Looking for participantsNCT06943495
What this trial is testing

Personalized vs. Fixed-Activity 177Lu-PSMA-617 Radiopharmaceutical Therapy (PRODIGY-2)

Who this might be right for
Metastatic Castrate Resistant Prostate Cancer (mCRPC)
Jean-Mathieu Beauregard 60
Not applicableActive Not RecruitingNCT04624828
What this trial is testing

Immune Response Evaluation in Oligorecurrent and Oligoprogressive Prostate Cancer Patients Treated With SBRT

Who this might be right for
Oligorecurrent and Oligoprogressive Prostate Cancer Patients
Istituto Clinico Humanitas 40
Post-approval studies (Phase 4)Study completedNCT01977651
What this trial is testing

Evaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With Enzalutamide

Who this might be right for
Metastatic Castration-resistant Prostate Cancer (mCRPC)
Astellas Pharma Global Development, Inc. 424
Testing effectiveness (Phase 2)Study completedNCT00083005
What this trial is testing

Docetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the Prostate

Who this might be right for
Prostate Cancer
National Institutes of Health Clinical Center (CC) 60
Post-approval studies (Phase 4)Study completedNCT00334139
What this trial is testing

Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast Cancer

Who this might be right for
Prostate CancerBreast CancerBone Metastasis
Novartis Pharmaceuticals 411
Testing effectiveness (Phase 2)Study completedNCT01685983
What this trial is testing

Abiraterone Acetate (JNJ-212082) and Prednisolone in Patients With Advanced Prostate Cancer

Who this might be right for
Prostate Cancer
Janssen Research & Development, LLC 82
Very early researchLooking for participantsNCT05045066
What this trial is testing

Immunological Effects of Vitamin D Replacement Among Black/African American Prostate Cancer Patients

Who this might be right for
Localized Prostate CarcinomaStage IV Prostate Cancer AJCC v8Locally Recurrent Prostate Carcinoma+1 more
Mayo Clinic 220
Next Page